tradingkey.logo
tradingkey.logo
Search

Advanced Biomed Inc

ADVB
Add to Watchlist
10.875USD
-3.485-24.27%
Close 07-28 16:00ETQuotes delayed by 15 min
15.03MMarket Cap
0.21P/E TTM

ADVB Income Statement

You can find the annual or quarterly income statement of Advanced Biomed Inc here for insights into the performance and operational efficiency of Advanced Biomed Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Operating expenses
-31.85%519.84K
-24.55%396.64K
0.75%523.91K
72.09%1.21M
2.32%762.74K
-19.28%525.73K
18.12%520.03K
-30.86%704.61K
-5.67%745.41K
-23.66%651.30K
7.74%440.25K
-5.85%1.02M
--790.23K
--853.21K
--408.62K
--1.08M
R&D expenses
-2.89%243.23K
-23.44%186.33K
29.88%235.99K
12.01%234.22K
-20.11%250.46K
29.19%243.38K
7.40%181.70K
-57.16%209.11K
50.60%313.51K
-66.96%188.39K
45.09%169.19K
-15.00%488.17K
--208.17K
--570.23K
--116.61K
--574.29K
Depreciation, depletion, and amortization
-88.06%9.33K
-85.40%14.46K
-53.05%47.99K
-58.16%64.40K
-5.87%78.14K
10.58%99.07K
14.45%102.22K
-7.83%153.92K
87.84%83.02K
23.26%89.59K
-45.71%89.31K
45.99%166.99K
--44.19K
--72.68K
--164.51K
--114.38K
Operating profit
31.85%-519.84K
24.55%-396.64K
-0.75%-523.91K
-72.09%-1.21M
-2.32%-762.74K
19.28%-525.73K
-18.12%-520.03K
30.86%-704.61K
5.67%-745.41K
23.66%-651.30K
-7.74%-440.25K
5.85%-1.02M
---790.23K
---853.21K
---408.62K
---1.08M
Net non-operating interest income (expenses)
Non-operating interest income
----
-40.29%9.21K
4380.00%448.00
-71.53%9.51K
-100.00%0.00
-22.78%15.42K
-28.57%10.00
57.01%33.41K
--104.00
8813.39%19.97K
-96.84%14.00
--21.28K
----
--224.00
--443.00
----
Gains from sale of securities
104.99%31.01K
88.25%-42.94K
-45.95%136.26K
404.50%501.56K
-118.24%-621.98K
---365.51K
176.00%252.10K
---164.72K
---284.99K
----
---331.69K
----
----
----
----
----
Special income (expenses)
--0.00
--7.35M
----
----
----
----
----
----
----
----
----
----
----
----
----
---1.62M
Other non-operating income (expenses)
-100.83%-7.00
367.70%85.87K
-87.06%303.00
-100.55%-145.00
103.24%841.00
-106.60%-32.08K
287.58%2.34K
103.89%26.53K
-109.51%-25.93K
3.93%485.99K
100.08%604.00
-40736.13%-682.69K
--272.67K
--467.60K
---740.54K
--1.68K
Income before tax
64.67%-488.94K
871.25%7.00M
-45.68%-386.90K
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.90K
65.57%-265.58K
51.84%-809.39K
-103.86%-1.06M
62.29%-145.34K
32.85%-771.32K
37.73%-1.68M
---518.11K
---385.39K
---1.15M
---2.70M
Income tax
--0.00
--0.00
----
----
--0.00
--0.00
----
----
--0.00
----
----
----
----
----
----
--0.00
Income after tax
64.67%-488.94K
871.25%7.00M
-45.68%-386.90K
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.90K
65.57%-265.58K
51.84%-809.39K
-103.86%-1.06M
62.29%-145.34K
32.85%-771.32K
37.73%-1.68M
---518.11K
---385.39K
---1.15M
---2.70M
Net income from continuous operations
64.67%-488.94K
871.25%7.00M
-45.68%-386.90K
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.90K
65.57%-265.58K
51.84%-809.39K
-103.86%-1.06M
62.29%-145.34K
32.85%-771.32K
37.73%-1.68M
---518.11K
---385.39K
---1.15M
---2.70M
Net income from discontinued operations
----
---144.26K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
64.67%-488.94K
855.36%6.86M
-45.68%-386.90K
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.90K
65.57%-265.58K
51.84%-809.39K
-103.86%-1.06M
62.29%-145.34K
32.85%-771.32K
37.73%-1.68M
---518.11K
---385.39K
---1.15M
---2.70M
Net income attributable to common shareholders
64.67%-488.94K
855.36%6.86M
-45.68%-386.90K
13.32%-701.61K
-31.02%-1.38M
-524.65%-907.90K
65.57%-265.58K
51.84%-809.39K
-103.86%-1.06M
62.29%-145.34K
32.85%-771.32K
37.73%-1.68M
---518.11K
---385.39K
---1.15M
---2.70M
Basic earnings per share
-463.15%-0.38
15208.94%6.34
-45.72%-0.02
13.29%-0.03
-38.43%-0.07
-524.26%-0.04
65.57%-0.01
51.84%-0.04
-103.88%-0.05
62.27%-0.01
32.86%-0.04
37.73%-0.08
---0.02
---0.02
---0.05
---0.12
Diluted earnings per share
-463.15%-0.38
15208.94%6.34
-45.72%-0.02
13.29%-0.03
-38.43%-0.07
-524.26%-0.04
65.57%-0.01
51.84%-0.04
-103.88%-0.05
62.27%-0.01
32.86%-0.04
37.73%-0.08
---0.02
---0.02
---0.05
---0.12
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Advanced Biomed Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing ADVB stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Advanced Biomed Inc's net income for the year?

Advanced Biomed Inc posted -3.26M in net income for fiscal year 2025.

How much net income did Advanced Biomed Inc post in the last quarter?

Advanced Biomed Inc reported -488.94K in net income for the latest quarter。

What was Advanced Biomed Inc's annual operating profit?

Advanced Biomed Inc's operating income was -3.02M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.